Port Erin Biopharma

Port Erin creates value for shareholders through investing in companies that have the potential to generate substantial revenues through the development of biopharmaceutical drugs. The group is beginning to capitalise on the new wave of modern medicines which pharmaceutical companies are producing. These opportunities will only advance further with time and Port Erin, directed by Jim Mellon, is in a prime position to exploit this.